| [1] |
van Zuuren EJ. Rosacea[J]. N Engl J Med, 2017,377(18):1754⁃1764. DOI: 10.1056/NEJMcp1506630.
|
| [2] |
Ahn CS, Huang WW. Rosacea pathogenesis[J]. Dermatol Clin, 2018,36(2):81⁃86. DOI: 10.1016/j.det.2017.11.001.
|
| [3] |
Piggott T, Morgan RL, Cuello-Garcia CA, et al. Grading of Recommendations Assessment, Development, and Evaluations (GRADE) notes: extremely serious, GRADE's terminology for rating down by three levels[J]. J Clin Epidemiol, 2020,120:116⁃120. DOI: 10.1016/j.jclinepi.2019.11.019.
|
| [4] |
郝飞, 宋志强. 提高对玫瑰痤疮的认识水平[J]. 中华皮肤科杂志, 2017,50(3):153⁃155. DOI: 10.3760/cma.j.issn.0412⁃4030. 2017.03.001.
|
| [5] |
Schaller M, Almeida L, Bewley A, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel[J]. Br J Dermatol, 2020,182(5):1269⁃1276. DOI: 10.1111/bjd.18420.
|
| [6] |
Webster G, Schaller M. Ocular rosacea: a dermatologic perspective[J]. J Am Acad Dermatol, 2013,69(6 Suppl 1):S42⁃S43. DOI: 10.1016/j.jaad.2013.04.040.
|
| [7] |
李吉, 谢红付. 如何避免玫瑰痤疮的误诊[J]. 中华皮肤科杂志, 2024,57(2):119⁃122. DOI: 10.35541/cjd.20230419.
|
| [8] |
Ciccarese G, Parodi A, Rebora A, et al. The possible combined action of different trigger agents in rosacea[J]. Actas Dermosifiliogr (Engl Ed), 2018,109(1):91⁃92. DOI: 10.1016/j.ad.2017.07.013.
|
| [9] |
Alia E, Feng H. Rosacea pathogenesis, common triggers, and dietary role: the cause, the trigger, and the positive effects of different foods[J]. Clin Dermatol, 2022,40(2):122⁃127. DOI: 10.1016/j.clindermatol.2021.10.004.
|
| [10] |
Liu X, Kim MK, Du D, et al. Patient education with new media integration self⁃management support model improves therapeutic outcomes of rosacea patients[J]. Patient Prefer Adherence, 2023,17:2395⁃2400. DOI: 10.2147/PPA.S431955.
|
| [11] |
Abram K, Silm H, Maaroos HI, et al. Risk factors associated with rosacea[J]. J Eur Acad Dermatol Venereol, 2010,24(5):565⁃571. DOI: 10.1111/j.1468⁃3083.2009.03472.x.
|
| [12] |
McCoy WH 4th. "Shedding Light" on how ultraviolet radiation triggers rosacea[J]. J Invest Dermatol, 2020,140(3):521⁃523. DOI: 10.1016/j.jid.2019.09.008.
|
| [13] |
Thiboutot D, Anderson R, Cook⁃Bolden F, et al. Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee[J]. J Am Acad Dermatol, 2020,82(6):1501⁃1510. DOI: 10.1016/j.jaad.2020.01.077.
|
| [14] |
Morgado⁃Carrasco D, Granger C, Trullas C, et al. Impact of ultraviolet radiation and exposome on rosacea: key role of photoprotection in optimizing treatment[J]. J Cosmet Dermatol, 2021,20(11):3415⁃3421. DOI: 10.1111/jocd.14020.
|
| [15] |
Baldwin H, Alexis A, Andriessen A, et al. Skin barrier deficiency in rosacea: an algorithm integrating OTC skincare products into treatment regimens[J]. J Drugs Dermatol, 2022,21(9):SF3595563⁃SF35955610. DOI: 10.36849/JDD.m0922.
|
| [16] |
Jabbehdari S, Memar OM, Caughlin B, et al. Update on the pathogenesis and management of ocular rosacea: an interdisciplinary review[J]. Eur J Ophthalmol, 2021,31(1):22⁃33. DOI: 10.1177/1120672120937252.
|
| [17] |
Drago F, Ciccarese G, Herzum A, et al. Rosacea and alcohol intake[J]. J Am Acad Dermatol, 2018,78(1):e25. DOI: 10.1016/j.jaad.2017.08.063.
|
| [18] |
Li G, Wang B, Zhao Z, et al. Excessive cleansing: an underestimating risk factor of rosacea in Chinese population[J]. Arch Dermatol Res, 2021,313(4):225⁃234. DOI: 10.1007/s00403⁃020⁃02095⁃w.
|
| [19] |
Teo WL. The "Maskne" microbiome ⁃ pathophysiology and therapeutics[J]. Int J Dermatol, 2021,60(7):799⁃809. DOI: 10. 1111/ijd.15425.
|
| [20] |
Alinia H, Tuchayi SM, Patel NU, et al. Rosacea triggers: alcohol and smoking[J]. Dermatol Clin, 2018,36(2):123⁃126. DOI: 10.1016/j.det.2017.11.007.
|
| [21] |
Drago F, Ciccarese G, Herzum A, et al. The association between cigarettes smoke, small intestine bacterial overgrowth and rosacea[J]. G Ital Dermatol Venereol, 2019,154(6):727⁃728. DOI: 10.23736/S0392⁃0488.18.05919⁃9.
|
| [22] |
Carter C, Martin K, Gordon C, et al. Exploring the lived experience of women with rosacea: visible difference and psychological impact[J]. Br J Dermatol, 2022,186(2):366⁃367. DOI: 10.1111/bjd.20768.
|
| [23] |
Moustafa F, Lewallen RS, Feldman SR. The psychological impact of rosacea and the influence of current management options[J]. J Am Acad Dermatol, 2014,71(5):973⁃980. DOI: 10.1016/j.jaad.2014.05.036.
|
| [24] |
蒋献, 宋德宇. 从心身医学视角认识玫瑰痤疮[J]. 中华皮肤科杂志, 2024,57(2):123⁃126. DOI: 10.35541/cjd.20230451.
|
| [25] |
Goh CL, Wu Y, Welsh B, et al. Challenges and real⁃world solutions for adoption of holistic skincare routine (cleansing, treatment, moisturization, and photoprotection) in acne, rosacea, atopic dermatitis, and sensitive skin: an expert consensus[J]. J Cosmet Dermatol, 2024,23(8):2516⁃2523. DOI: 10.1111/jocd. 16396.
|
| [26] |
Guder H, Guder S. Investigation of skincare habits and possible rosacea triggers of patients with rosacea: a prospective case⁃control study[J]. North Clin Istanb, 2024,11(1):27⁃37. DOI: 10. 14744/nci.2023.33410.
|
| [27] |
Fluhr JW, Darlenski R, Surber C. Glycerol and the skin: holistic approach to its origin and functions[J]. Br J Dermatol, 2008,159(1):23⁃34. DOI: 10.1111/j.1365⁃2133.2008.08643.x.
|
| [28] |
Nowicka D, Chilicka K, Dzieńdziora⁃Urbińska I, et al. Skincare in rosacea from the cosmetologist's perspective: a narrative review[J]. J Clin Med, 2022,12(1):115. DOI: 10.3390/jcm12010115.
|
| [29] |
McAleer MA, Powell FC. Complementary and alternative medicine usage in rosacea[J]. Br J Dermatol, 2008,158(5):1139⁃1141. DOI: 10.1111/j.1365⁃2133.2008.08471.x.
|
| [30] |
Del Rosso JQ. Management of facial erythema of rosacea: what is the role of topical α⁃adrenergic receptor agonist therapy?[J]. J Am Acad Dermatol, 2013,69(6 Suppl 1):S44⁃S56. DOI: 10.1016/j.jaad.2013.06.009.
|
| [31] |
Fowler J, Tan J, Jackson JM, et al. Treatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation of patient satisfaction with standard clinical endpoints of improvement of facial erythema[J]. J Eur Acad Dermatol Venereol, 2015,29(3):474⁃481. DOI: 10.1111/jdv.12587.
|
| [32] |
Paiva⁃Santos AC, Gonçalves T, Peixoto D, et al. Rosacea topical treatment and care: from traditional to new drug delivery systems[J]. Mol Pharm, 2023,20(8):3804⁃3828. DOI: 10.1021/acs.molpharmaceut.3c00324.
|
| [33] |
King A, Tan MG, Kirshen C, et al. Low⁃dose isotretinoin for the management of rosacea: a systematic review and meta⁃analysis[J]. J Eur Acad Dermatol Venereol, 2025,39(4):785⁃792. DOI: 10.1111/jdv.20315.
|
| [34] |
Papageorgiou P, Clayton W, Norwood S, et al. Treatment of rosacea with intense pulsed light: significant improvement and long⁃lasting results[J]. Br J Dermatol, 2008,159(3):628⁃632. DOI: 10.1111/j.1365⁃2133.2008.08702.x.
|
| [35] |
Kim BY, Moon HR, Ryu HJ. Comparative efficacy of short⁃pulsed intense pulsed light and pulsed dye laser to treat rosacea[J]. J Cosmet Laser Ther, 2019,21(5):291⁃296. DOI: 10.1080/14764172.2018.1528371.
|
| [36] |
Serowka KL, Saedi N, Dover JS, et al. Fractionated ablative carbon dioxide laser for the treatment of rhinophyma[J]. Lasers Surg Med, 2014,46(1):8⁃12. DOI: 10.1002/lsm.22184.
|
| [37] |
Yang J, Liu X, Cao Y, et al. 5⁃Aminolevulinic acid photodynamic therapy versus minocycline for moderate⁃to⁃severe rosacea: a single⁃center, randomized, evaluator⁃blind controlled study[J]. J Am Acad Dermatol, 2023,89(4):711⁃718. DOI: 10. 1016/j.jaad.2023.06.027.
|
| [38] |
Li A, Fang R, Mao X, et al. Photodynamic therapy in the treatment of rosacea: a systematic review[J]. Photodiagnosis Photodyn Ther, 2022,38:102875. DOI: 10.1016/j.pdpdt.2022. 102875.
|
| [39] |
Oh S, Son M, Park J, et al. Radiofrequency irradiation modulates TRPV1⁃related burning sensation in rosacea[J]. Molecules, 2021,26(5):1424. DOI: 10.3390/molecules26051424.
|
| [40] |
Choi JE, Werbel T, Wang Z, et al. Botulinum toxin blocks mast cells and prevents rosacea like inflammation[J]. J Dermatol Sci, 2019,93(1):58⁃64. DOI: 10.1016/j.jdermsci.2018.12.004.
|
| [41] |
Chen Y, Moore CD, Zhang JY, et al. TRPV4 Moves toward Center⁃Fold in Rosacea Pathogenesis[J]. J Invest Dermatol, 2017,137(4):801⁃804. DOI: 10.1016/j.jid.2016.12.013.
|
| [42] |
Aksoy B, Ekiz Ö, Unal E, et al. Systemic comorbidities associated with rosacea: a multicentric retrospective observational study[J]. Int J Dermatol, 2019,58(6):722⁃728. DOI: 10.1111/ijd.14353.
|